Cargando…

Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug.

Detalles Bibliográficos
Autores principales:	Cummings, J., McArdle, C. S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1986
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001410/ https://www.ncbi.nlm.nih.gov/pubmed/3718837

Ejemplares similares

An in vivo assessment of adriamycin-loaded albumin microspheres.
por: Goldberg, J. A., et al.
Publicado: (1992)

Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.
por: Martin, W. M., et al.
Publicado: (1980)

In vivo tumour-cell proliferation after adriamycin treatment.
por: Rowley, R., et al.
Publicado: (1982)

In vitro and in vivo drug disposition of cilengitide in animals and human
por: Dolgos, Hugues, et al.
Publicado: (2016)

Response kinetics of host and experimental solid tumour after adriamycin.
por: Hopkins, H. A., et al.
Publicado: (1978)

Sex Differences in Drug Disposition
por: Soldin, Offie P., et al.
Publicado: (2011)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.
por: Nishio, K., et al.
Publicado: (1990)

Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis
por: Takiue, Keiichi, et al.
Publicado: (2012)

The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer
por: Canna, K, et al.
Publicado: (2005)

In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
por: Tannock, I. F.
Publicado: (1980)

Model-Based Assessment of Dosing Strategies in Children for Monoclonal Antibodies Exhibiting Target-Mediated Drug Disposition
por: Zheng, S, et al.
Publicado: (2014)

Different distribution of adriamycin in normal and leukaemic rats.
por: Sonneveld, P., et al.
Publicado: (1981)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states
por: Sprangers, Mirjam A. G., et al.
Publicado: (2010)

Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres.
por: Jones, C., et al.
Publicado: (1989)

The effect of adriamycin and 4'-deoxydoxorubicin on cell survival of human lung tumour cells grown in monolayer and as spheroids.
por: Kerr, D. J., et al.
Publicado: (1986)

Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.
por: Merry, S., et al.
Publicado: (1989)

Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
por: Mooij, Miriam G., et al.
Publicado: (2015)

The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases
por: Al-Shaiba, R, et al.
Publicado: (2004)

Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity
por: Lauschke, Volker M., et al.
Publicado: (2019)

Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model.
por: Gabizon, A., et al.
Publicado: (1985)

The relationship between deprivation, tumour stage and the systemic inflammatory response in patients with primary operable breast cancer
por: Al Murri, A M, et al.
Publicado: (2004)

Acute Induction of Adriamycin‐resistance in Human Colon Carcinoma HT‐29 Cells Exposed to a Sublethal Dose of Adriamycin
por: Tomida, Akihiro, et al.
Publicado: (1995)

Modulation of Adriamycin Resistance in Human Breast Carcinoma MCF‐7 Cells in vitro and in vivo by Medroxyprogesterone Acetate
por: Ishida, Hiroyuki, et al.
Publicado: (1994)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

Species Differences in Tryptophan Metabolism and Disposition
por: Badawy, Abdulla A-B, et al.
Publicado: (2022)

In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
por: Murata, Yukiko, et al.
Publicado: (2022)

Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro.
por: Eichholtz-Wirth, H.
Publicado: (1980)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

Intertidal clams exhibit population synchrony across spatial and temporal scales
por: Barber, Julie S., et al.
Publicado: (2018)

Macro- and micronutrient disposition in an ex vivo model of extracorporeal membrane oxygenation
por: Estensen, Kristine, et al.
Publicado: (2014)

Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition
por: Westin, Andreas A., et al.
Publicado: (2017)

Racial Disparity in Drug Disposition in the Digestive Tract
por: Gao, Song, et al.
Publicado: (2021)

Isolation and preliminary characterisation of cDNA clones representing mRNAs associated with tumour progression and metastasis in colorectal cancer.
por: Elvin, P., et al.
Publicado: (1988)

Synthesis and Functionalisation of Superparamagnetic Nano-Rods towards the Treatment of Glioblastoma Brain Tumours
por: Habra, Kinana, et al.
Publicado: (2021)

A short-term in vitro test for tumour sensitivity to adriamycin based on flow cytometric DNA analysis.
por: Engelholm, S. A., et al.
Publicado: (1983)

Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1
por: Järveläinen, Harri A., et al.
Publicado: (2023)

Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines.
por: Snow, K., et al.
Publicado: (1991)

Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer
por: Hong, Woo Sung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_snjiln62ddkp59qgdjpupt6dak